FDA Clarifies Criteria for Accepting Reportable Manufacturing Changes For Biologics
Executive Summary
To reduce the number of unnecessary supplements being submitted to the agency, US FDA draft guidance clarifies which types of biologics manufacturing changes are considered minor and can be included in annual reports. The agency said that too many minor changes are being submitted as supplements.